Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons

Journal of Infectious Diseases

Volumn 198, Issue 9, 2008, Pages 1398-1406

  Obata, Fumiko ^a   Tohyama, Koujiro ^c   Bonev, Adrian D ^b   Kolling, Glynis L ^a   Keepers, Tiffany R ^a   Gross, Lisa K ^a   Nelson, Mark T ^b   Sato, Shigehiro ^c   Obrig, Tom G ^a,d  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLOBOTRIAOSYLCERAMIDE; VEROTOXIN 2;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOREACTIVITY; LAMELLIPODIUM; LUMBAR SPINAL CORD; MALE; MOTONEURON; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINAL PARALYSIS; WEIGHT REDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CENTRAL NERVOUS SYSTEM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MOTOR NEURONS; NEUROGLIA; NEURONS; SHIGA TOXIN 2; SPECIFIC PATHOGEN-FREE ORGANISMS; TRIHEXOSYLCERAMIDES; WEIGHT LOSS;

EID: 54249114405     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/591911     Document Type: Article

References (48)

1. Valles PG, Pesle S, Piovano L, et al. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock. Medicina (B Aires) 2005; 65:395-401.
2. Verweyen HM, Karch H, Allerberger F, Zimmerhackl LB. Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: a prospective study in Germany and Austria. Infection 1999; 27:341-7.
3. Milne LM, Plom A, Strudley I, et al. Escherichia coli O157 incident associated with a farm open to members of the public. Commun Dis Public Health 1999; 2:22-6.
4. Cimolai N, Carter JE. Bacterial genotype and neurological complications of Escherichia coli O157:H7-associated haemolytic uraemic syndrome. Acta Paediatr 1998; 87:593-4.
5. Perez N, Spizzirri F, Rahman R, Suarez A, Larrubia C, Lasarte P. Steroids in the hemolytic uremic syndrome. Pediatr Nephrol 1998; 12:101-4.
6. Tapper D, Tarr P, Avner E, Brandt J, Waldhausen J. Lessons learned in the management of hemolytic uremic syndrome in children. J Pediatr Surg 1995; 30:158-63.
7. Tinaztepe K, Akkok N, Tinaztepe B. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases. Turk J Pediatr 1993; 35: 23-36.
8. Cimolai N, Morrison BJ, Carter JE. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome. Pediatrics 1992; 90:616-21.
9. Hughes DA, Beattie TJ, Murphy AV. Haemolytic uraemic syndrome: 17 years' experience in a Scottish paediatric renal unit. Scott Med J 1991; 36:9-12.
10. Hahn JS, Havens PL, Higgins JJ, O'Rourke PP, Estroff JA, Strand R. Neurological complications of hemolytic-uremic syndrome. J Child Neurol 1989; 4:108-13.
11. Taylor CM, White RH, Winterborn MH, Rowe B. Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) 1986; 292:1513-6.
12. Sheth KJ, Swick HM, Haworth N. Neurological involvement in hemolytic-uremic syndrome. Ann Neurol 1986; 19:90-3.
13. Bos AP, Donckerwolcke RA, van Vught AJ. The hemolytic-uremic syndrome: prognostic significance of neurological abnormalities. Helv Paediatr Acta 1985; 40:381-9.
14. Lopez EL, Diaz M, Grinstein S, et al. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis 1989; 160:469-75.
15. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, Kobayashi JM. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis 1989; 160: 994-8.
16. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002; 186:493-500.
17. Khine AA, Lingwood CA. Capping and receptor-mediated endocytosis of cell-bound verotoxin (Shiga-like toxin). I. Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization. J Cell Physiol 1994; 161:319-32.
18. Sandvig K, Olsnes S, Brown JE, Petersen OW, van Deurs B. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J Cell Biol 1989; 108:1331-43.
19. Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH, van Deurs B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 1992; 358:510-2.
20. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988; 171:45-50.
21. Waddell T, Cohen A, Lingwood CA. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc Natl Acad Sci USA 1990; 87:7898-901.
22. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 1993; 268:15484-8.
23. Hughes AK, Ergonul Z, Stricklett PK, Kohan DE. Molecular basis for high renal cell sensitivity to the cytotoxic effects of shigatoxin-1: upregulation of globotriaosylceramide expression. J Am Soc Nephrol 2002; 13:2239-45.
24. Ergonul Z, Hughes AK, Kohan DE. Induction of apoptosis of human brain microvascular endothelial cells by Shiga toxin 1. J Infect Dis 2003; 187:154-8.
25. Blinzinger K, Kreutzberg G. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z Zellforsch Mikrosk Anat 1968; 85:145-57.
26. Moran LB, Graeber MB. The facial nerve axotomy model. Brain Res Brain Res Rev 2004; 44:154-78.
27. Pastor AM, Moreno-Lopez B, De La Cruz RR, Delgado-Garcia JM. Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: ultrastructural and synaptic alterations. Neuroscience 1997; 81:457-78.
28. Trapp BD, Wujek JR, Criste GA, et al. Evidence for synaptic stripping by cortical microglia. Glia 2007; 55:360-8.
29. Filosa JA, Bonev AD, Nelson MT. Calcium dynamics in cortical astrocytes and arterioles during neurovascular coupling. Circ Res 2004; 95: e73-81.
30. Zonta M, Angulo MC, Gobbo S, et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 2003; 6:43-50.
31. Melton-Celsa AR, O'Brien AD. Shiga toxins of Shigella dysenteriae and Escherichia coli. In: Aktories K, Just I, eds. Handbook of experimental phamacology. Freiburg: Springer, 2000:385-406.
32. Keepers TR, Psotka MA, Gross LK, Obrig TG. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J AmSoc Nephrol 2006; 17:3404-14.
33. Tokuyasu KT. Use of poly(vinylpyrrolidone) and poly(vinyl alcohol) for cryoultramicrotomy. Histochem J 1989; 21:163-71.
34. Akagi T, Ishida K, Hanasaka T, et al. Improved methods for ultracryotomy of CNS tissue for ultrastructural and immunogold analyses. J Neurosci Methods 2006; 153:276-82.
35. Peters O, Schipke CG, Hashimoto Y, Kettenmann H. Different mechanisms promote astrocyte Ca2+ waves and spreading depression in the mouse neocortex. J Neurosci 2003; 23:9888-96.
36. Yuste R, Majewska A, Cash SS, Denk W. Mechanisms of calcium influx into hippocampal spines: heterogeneity among spines, coincidence detection by NMDA receptors, and optical quantal analysis. J Neurosci 1999; 19:1976-87.
37. Siegler RL, Pavia AT, Christofferson RD, Milligan MK. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 1994; 94:35-40.
38. Tzipori S, Chow CW, Powell HR. Cerebral infection with Escherichia coli O157:H7 in humans and gnotobiotic piglets. J Clin Pathol 1988; 41: 1099-103.
39. Utsunomiya I, Ren J, Taguchi K, et al. Immunohistochemical detection of verotoxin receptors in nervous system. Brain Res Brain Res Protoc 2001; 8:99-103.
40. Goldstein J, Loidl CF, Creydt VP, Boccoli J, Ibarra C. Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res 2007; 1161:106-15.
41. Katagiri YU, Mori T, Nakajima H, et al. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/ CD77) in low density, detergent-insoluble microdomains. J Biol Chem 1999; 274:35278-82.
42. Takenouchi H, Kiyokawa N, Taguchi T, et al. Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells. J Cell Sci 2004; 117:3911-22.
43. Hehnly H, Sheff D, Stamnes M. Shiga toxin facilitates its retrograde transport by modifying microtubule dynamics. Mol Biol Cell 2006; 17: 4379-89.
44. Sugatani J, Igarashi T, Munakata M, et al. Activation of coagulation in C57BL/6 mice given verotoxin 2 (VT2) and the effect of coadministration of LPS with VT2. Thromb Res 2000; 100:61-72.
45. Bale JF Jr, Brasher C, Siegler RL. CNS manifestations of the hemolytic-uremic syndrome: relationship to metabolic alterations and prognosis. Am J Dis Child 1980; 134:869-72.
46. Hamano S, Nakanishi Y, Nara T, et al. Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paediatr 1993; 82:454-8.
47. Steinborn M, Leiz S, Rudisser K, Griebel M, Harder T, Hahn H. CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol 2004; 34:805-10.
48. Ogura H, Takaoka M, Kishi M, et al. Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol 1998; 19:1144 -5.